121 related articles for article (PubMed ID: 8296622)
1. Relationship between disease activity and ANCA level by ELISA in the long-term management of vasculitis.
De'Oliviera J; Gaskin G; Dash A; Rees AJ; Pusey CD
Adv Exp Med Biol; 1993; 336():303-4. PubMed ID: 8296622
[TBL] [Abstract][Full Text] [Related]
2. Relationship between disease activity and anti-neutrophil cytoplasmic antibody concentration in long-term management of systemic vasculitis.
De'Oliviera J; Gaskin G; Dash A; Rees AJ; Pusey CD
Am J Kidney Dis; 1995 Mar; 25(3):380-9. PubMed ID: 7872315
[TBL] [Abstract][Full Text] [Related]
3. Relapses in patients with a systemic vasculitis.
Gordon M; Luqmani RA; Adu D; Greaves I; Richards N; Michael J; Emery P; Howie AJ; Bacon PA
Q J Med; 1993 Dec; 86(12):779-89. PubMed ID: 7906421
[TBL] [Abstract][Full Text] [Related]
4. Anti-neutrophil cytoplasmic antibody-associated paraneoplastic vasculitis.
Navarro JF; Quereda C; Rivera M; Navarro FJ; Ortuño J
Postgrad Med J; 1994 May; 70(823):373-5. PubMed ID: 8016013
[TBL] [Abstract][Full Text] [Related]
5. Pooled intravenous immunoglobulin in the management of systemic vasculitis.
Jayne DR; Lockwood CM
Adv Exp Med Biol; 1993; 336():469-72. PubMed ID: 8296659
[TBL] [Abstract][Full Text] [Related]
6. Alpha-1-antitrypsin, CRP and interleukin-6 in ANCA-positive vasculitis.
Grönhagen-Riska C; Teppo AM; Honkanen E; Ikäheimo R
Adv Exp Med Biol; 1993; 336():337-40. PubMed ID: 8296630
[TBL] [Abstract][Full Text] [Related]
7. ANCA and predicting relapse in systemic vasculitis.
Jayne DR; Gaskin G; Pusey CD; Lockwood CM
QJM; 1995 Feb; 88(2):127-33. PubMed ID: 7704563
[TBL] [Abstract][Full Text] [Related]
8. [Treatment of patients with Wegener's granulomatosis or ANCA-associated vasculitis].
Tervaert JW; Stegeman CA
Ned Tijdschr Geneeskd; 2003 Nov; 147(46):2265-7. PubMed ID: 14655291
[TBL] [Abstract][Full Text] [Related]
9. Comparison of anti-PR3 capture and anti-PR3 direct ELISA for detection of antineutrophil cytoplasmic antibodies (ANCA) in long-term clinical follow-up of PR3-ANCA-associated vasculitis patients.
Arranz O; Ara J; Rodriguez R; Quintó L; Font J; Mirapeix E; Darnell A
Clin Nephrol; 2001 Oct; 56(4):295-301. PubMed ID: 11680659
[TBL] [Abstract][Full Text] [Related]
10. ANCA titres, even of IgG subclasses, and soluble CD14 fail to predict relapses in patients with ANCA-associated vasculitis.
Nowack R; Grab I; Flores-Suarèz LF; Schnülle P; Yard B; van der Woude FJ
Nephrol Dial Transplant; 2001 Aug; 16(8):1631-7. PubMed ID: 11477166
[TBL] [Abstract][Full Text] [Related]
11. A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies.
Jayne D; Rasmussen N; Andrassy K; Bacon P; Tervaert JW; Dadoniené J; Ekstrand A; Gaskin G; Gregorini G; de Groot K; Gross W; Hagen EC; Mirapeix E; Pettersson E; Siegert C; Sinico A; Tesar V; Westman K; Pusey C;
N Engl J Med; 2003 Jul; 349(1):36-44. PubMed ID: 12840090
[TBL] [Abstract][Full Text] [Related]
12. What is new in the therapy of ANCA-associated vasculitides? Take home messages from the 12th workshop on ANCA and systemic vasculitides.
de Groot K; Jayne D
Clin Nephrol; 2005 Dec; 64(6):480-4. PubMed ID: 16370164
[TBL] [Abstract][Full Text] [Related]
13. Anti-neutrophil cytoplasmic antibodies and disease activity during long-term follow-up of 70 patients with systemic vasculitis.
Gaskin G; Savage CO; Ryan JJ; Jones S; Rees AJ; Lockwood CM; Pusey CD
Nephrol Dial Transplant; 1991; 6(10):689-94. PubMed ID: 1754104
[TBL] [Abstract][Full Text] [Related]
14. Positive classic antineutrophil cytoplasmic antibody (C-ANCA) titer at switch to azathioprine therapy associated with relapse in proteinase 3-related vasculitis.
Slot MC; Tervaert JW; Boomsma MM; Stegeman CA
Arthritis Rheum; 2004 Apr; 51(2):269-73. PubMed ID: 15077271
[TBL] [Abstract][Full Text] [Related]
15. Prediction of relapses in PR3-ANCA-associated vasculitis by assessing responses of ANCA titres to treatment.
Sanders JS; Huitma MG; Kallenberg CG; Stegeman CA
Rheumatology (Oxford); 2006 Jun; 45(6):724-9. PubMed ID: 16399845
[TBL] [Abstract][Full Text] [Related]
16. [A preliminary study of the significance of autoantibodies against light chain of myeloperoxidase on pulmonary damages in myeloperoxidase-antineutrophil cytoplasmic antibody associated vasculitis].
Zhang L; Shuai Z; Hu Z; Zhang M; Chen S
Zhonghua Nei Ke Za Zhi; 2015 Jun; 54(6):511-6. PubMed ID: 26359012
[TBL] [Abstract][Full Text] [Related]
17. [ANCA(antineutrophil cytoplasmic antibodies)-associated vasculitis in a man with extreme fatigue, fever and progressive renal dysfunction].
Bakashvili N; Swaak AJ; Tervaert JW; Dees A
Ned Tijdschr Geneeskd; 2008 Apr; 152(17):1009-14. PubMed ID: 18549177
[TBL] [Abstract][Full Text] [Related]
18. Pulse versus daily oral cyclophosphamide for induction of remission in ANCA-associated vasculitis: long-term follow-up.
Harper L; Morgan MD; Walsh M; Hoglund P; Westman K; Flossmann O; Tesar V; Vanhille P; de Groot K; Luqmani R; Flores-Suarez LF; Watts R; Pusey C; Bruchfeld A; Rasmussen N; Blockmans D; Savage CO; Jayne D;
Ann Rheum Dis; 2012 Jun; 71(6):955-60. PubMed ID: 22128076
[TBL] [Abstract][Full Text] [Related]
19. Predictors of relapse and treatment resistance in antineutrophil cytoplasmic antibody-associated small-vessel vasculitis.
Hogan SL; Falk RJ; Chin H; Cai J; Jennette CE; Jennette JC; Nachman PH
Ann Intern Med; 2005 Nov; 143(9):621-31. PubMed ID: 16263884
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the FIDIS vasculitis multiplex immunoassay for diagnosis and follow-up of ANCA-associated vasculitis and Goodpasture's disease.
Damoiseaux J; Vaessen M; Knapen Y; Csernok E; Stegeman CA; Van Paassen P; Tervaert JW
Ann N Y Acad Sci; 2007 Aug; 1109():454-63. PubMed ID: 17785334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
